Some people experience complications immediately after their operation, while for others they develop years later. Complications may range from mild to severe. They can have physical impacts and affect your quality of life. In some surgical mesh products were withdrawn from use in Aotearoa New Zealand.
These were products used for pelvic organ prolapse POP via transvaginal implantation inserted via your vagina and a single incision mini-sling for the treatment of SUI. Other devices may be used by some surgeons using laparoscopic surgery.
There are now only limited situations where mesh might be considered, eg, for a mid-urethral sling or Sacro-colpopexy. Each type of mesh procedure carries its own risks and benefits. As part of the informed consent process, you need to be fully informed on what is involved in the procedure, the possible benefits and risks of complications, as well as any alternative treatment options both surgical and non-surgical.
If you are considering surgical mesh to treat stress urinary incontinence you should receive a copy of this document to discuss with your surgeon and support your decision-making: Considering surgical mesh to treat stress urinary incontinence?
Take the time you need to read it and make sure you understand it. If not, ask someone to help you with that. Also, discuss any concerns or questions that you have with your surgeon. You have the right to seek a second opinion if you are not satisfied with the information you receive or would like further advice on your treatment options.
Yale Medicine obstetrician-gynecologists and urologists who subspecialize in female pelvic medicine and reconstructive surgery say they worry women will mistakenly think the FDA ruling involves all pelvic floor surgeries that use mesh. Even though this one procedure is off the table for now, there other good treatment options, both surgical and nonsurgical. And, Dr. Below, we asked Drs.
Rickey and Harmanli questions about mesh and pelvic floor disorders. Surgical mesh is a net-like medical implant that is used to provide support when repairing weakened or damaged tissue. Most surgical mesh comes from synthetic man-made materials or animal tissue.
It is used in a variety of medical procedures, including hernia repair and heart stents. The type most often used to treat pelvic floor disorders is made of the synthetic polypropylene. For pelvic organ prolapse repair, the mesh graft is placed to reinforce the weakened vaginal wall. This is different than the way it is used for stress urinary incontinence, in which a thin strip is placed to support the urethra. Polypropylene mesh has been used for abdominal hernias since the s.
Rickey explains. Also, this technique is not always effective long-term, Dr. Harmanli notes. So, in the s, gynecologic and urologic surgeons began to experiment with mesh, cutting it themselves and inserting it through abdominal incisions.
These include mesh exposure and erosion — when the mesh pokes through the vaginal wall or cuts through internal tissue — vaginal scarring, fistula formation, painful sex, and pelvic, back and leg pains.
Some of these complications may occur years after surgery and can be difficult to treat. And although serious complications appear to be rare, given the thousands of women who have had the implants, the numbers of women suffering adverse reactions is high.
Similar class actions involving thousands of women are also under way in the UK and US. In many of the cases, issues have been raised around informed consent. The Australian government is also holding a Senate inquiry into the use of transvaginal mesh examining any financial or other incentives provided to medical practitioners to use or promote transvaginal mesh implants, the lack of data available on how many procedures were performed, and the type and incidence of health problems women have experienced.
The next round of public hearings will be held in Sydney on 18 September. In the UK, a government report estimated the procedure was performed on about about 17, women per year suffering stress incontinence and that these numbers had remained stable for a few years. The number of vaginal mesh implants used for prolapse peaked around with 3, implants sold to hospitals, but had dropped gradually to about 2, per year, the report found.
In the US, the Food and Drug Administration [FDA] issued safety warnings to doctors and consumers in about an increase in adverse event reports related to mesh. The latest available FDA figures show approximately , women in the US undergo surgical procedures for prolapse each year and approximately , underwent surgical procedures to repair stress incontinence.
There is no accurate data available to track the number of women who have had a mesh implant for the treatment of prolapse or incontinence in Australia, Higgs says. It also makes it hard to determine complication rates related to mesh unless women are signed up to clinical trials. Brands of mesh have been pulled from the market around the world by manufacturers, and brands and types that have been studied have been replaced by newer versions that doctors have less evidence about.
This makes it difficult to understand if some have higher complication rates or are more effective than others. The mesh implants are designed to be permanent and during the first weeks after surgery become embedded in the surrounding tissue to provide better pelvic support.
If the implant becomes exposed in the vagina, doctors normally cut away the mesh and put in some stitches, which can sometimes be done under local anaesthetic. However, if the patient is suffering from more permanent complications, such as pain, full removal can require hours of surgery and doctors have to also weigh up the risk of damage to nerves and nearby organs, including the bladder and bowel. Higgs said women who had undergone a mesh procedure in the past and who are well are unlikely to suffer any adverse effects or complications.
0コメント